|
|
|
| Comparative Study of Cisplatin Combined With Gemcitabine and Paclitaxel in the Treatment of Recurrent Nasopharyngeal Carcinoma |
| Zhang Zhansheng1, Cao Jing2 |
1. Department of Oncology,Zhumadian Cancer Hospital,Zhumadian 463000,China;
2. Department of Radiotherapy,Zhumadian First people's Hospital,Zhumadian 463000,China |
|
|
|
|
Abstract Objective To investigate the comparative study of cisplatin combined with gemcitabine and paclitaxel in the treatment of recurrent nasopharyngeal carcinoma. Methods 85 patients with recurrent nasopharyngeal carcinoma treated in our hospital from July 2018 to March 2020 were selected as the research objects.According to the random number table method,they were divided into group A（42 cases）and group B（43 cases）.Group A received cisplatin + paclitaxel（TP）regimen,and group B received cisplatin + gemcitabine（GP）regimen.The short-term efficacy,tumor markers [platelet-derived growth factor（PDGF-BB）,serum epithelial cadherin（SE-CAD）] and toxicity reactions were observed in the two groups. Results The short-term efficacy of the two groups was compared（P>0.05）;after treatment,the levels of PDGF-BB and SE-CAD in the two groups were decreased,compared with those before treatment（P<0.05）;the levels of PDGF-BB and SE-CAD in the two groups after treatment were compared（P>0.05）;the gastrointestinal reaction in group B was lower than that in group A（P>0.05）. Conclusion GP and TP regimens have good efficacy in recurrent nasopharyngeal carcinoma,which can inhibit tumor growth.However,compared with TP Regimen,GP regimen has less gastrointestinal reaction and higher safety.
|
|
Received: 11 September 2020
|
|
|
|
|
|
[1] 林灿峰,李东升,林柏翰,等.鼻咽癌治疗后局部复发回顾性研究[J].中华肿瘤防治杂志,2017,24(3):188-191.
[2] 纪荣佳,管凯,庄建发,等.吉西他滨联合奈达铂化疗后序贯行姑息性放疗治疗复发性鼻咽癌的疗效及不良反应分析[J].医学综述,2017,23(11):2285-2288.
[3] 潘学兵,何宇,邵俊伟,等.吉西他滨或紫杉醇联合奈达铂治疗局部晚期鼻咽癌效果比较[J].肿瘤研究与临床,2017,29(6):394-397.
[4] 中国抗癌协会鼻咽癌专业委员会.复发鼻咽癌治疗专家共识[J].中华放射肿瘤学杂志,2018,27(1):16-22.
[5] 刘耿淳,申良方.血清长链非编码RNA MALAT1和AFAP1-AS1与鼻咽癌临床病理特征和预后的关系[J].实用肿瘤学杂志,2019,33(6):513-518.
[6] 杨利,徐志渊,李济时,等.顺铂加卡培他滨诱导化疗治疗局部晚期鼻咽癌的疗效及毒副反应[J].现代肿瘤医学,2018,26(4):516-519.
[7] 郑法德,冉献贵,杨瑞青,等.白蛋白结合型紫杉醇与顺铂联合吉西他滨治疗肺鳞状细胞癌疗效的对比研究[J].癌症进展,2017,15(9):1026-1028.
[8] 杜伟一,陈淑莲,李国强,等.两种方案治疗复发或转移性鼻咽癌的疗效对比及对血清上皮型钙黏蛋白、血小板源性生长因子水平的影响[J].中国医师进修杂志,2020,43(3):198-202.
[9] 郑莉,廖文军,徐鹏,等.吉西他滨顺铂和紫杉醇顺铂方案对鼻咽癌诱导化疗后肿瘤体积变化和早期生存结果比较[J].实用医院临床杂志,2018,15(3):70-72.
[10] 吴建强,黄成,赵浩,等.培美曲塞钠和吉西他滨分别联合顺铂治疗晚期膀胱尿路上皮癌的安全性和有效性的临床对比研究[J].国际泌尿系统杂志,2019,39(5):811-815. |
| [1] |
. [J]. journal1, 2021, 41(1): 90-91. |
|
|
|
|
2021, Vol. 41 
